Vinay PrasadMD, MPH ยท hematologist-oncologist and professor of epidemiology and biostatistics
Ask what the trials showed for deaths from any cause before you agree, because on that measure he says they are negative.
What it rests onHis argument is about which endpoint counts. Deaths from lung cancer specifically do not include the deaths screening itself causes, and he gives the case: a scan finds a small shadow, a needle biopsy punctures the lung, and the patient dies during the procedure, which that measure records as no lung cancer death. Deaths from any cause count every such event, and he says the two main trials are negative on it and that patients should be told so. He also concedes the strongest argument for screening and says the evidence for it has never been published: if early detection meant smaller operations, fewer chest tubes and less chemotherapy, he would support it, but no lung screening trial has reported those numbers, and he invites anyone to send him one that has.
Source: drvinayprasad.com ↗
